Payment overview · 2025
General Payments
$20.92
1 reported records · 1 companies
Healthcare provider profile · identity verified
Gregory A Baird, MD
Allopathic & Osteopathic Physicians|General Practice · SOUTH JORDAN, UT · NPI 1902148133
Verified facts
What the public records show
CMS Open Payments records show Gregory A Baird, MD received $20.92 in general payments during 2025 across 1 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $20.92 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $20.92 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $20.92 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 761 | 139 |
| Levothyroxine Sodium | Levothyroxine Sodium | 475 | 81 |
| Trazodone Hcl | Trazodone Hcl | 458 | 92 |
| Lisinopril | Lisinopril | 408 | 98 |
| Gabapentin | Gabapentin | 371 | 91 |
| Eliquis | Apixaban | 360 | 52 |
| Duloxetine Hcl | Duloxetine Hcl | 358 | 49 |
| Furosemide | Furosemide | 308 | 74 |
| Metformin Hcl | Metformin Hcl | 306 | 74 |
| Potassium Chloride | Potassium Chloride | 287 | 59 |
| Alendronate Sodium | Alendronate Sodium | 254 | 44 |
| Mirtazapine | Mirtazapine | 213 | 38 |
| Quetiapine Fumarate | Quetiapine Fumarate | 202 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 199 | 39 |
| Escitalopram Oxalate | Escitalopram Oxalate | 195 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 179 | 41 |
| Paroxetine Hcl | Paroxetine Hcl | 175 | 27 |
| Jardiance | Empagliflozin | 170 | 32 |
| Omeprazole | Omeprazole | 155 | 44 |
| Losartan Potassium | Losartan Potassium | 153 | 38 |
| Amlodipine Besylate | Amlodipine Besylate | 148 | 44 |
| Divalproex Sodium | Divalproex Sodium | 145 | 36 |
| Buspirone Hcl | Buspirone Hcl | 141 | 23 |
| Terbinafine Hcl | Terbinafine Hcl | 141 | 38 |
| Carvedilol | Carvedilol | 140 | 40 |
| Baclofen | Baclofen | 125 | 19 |
| Metoprolol Tartrate | Metoprolol Tartrate | 114 | 26 |
| Sertraline Hcl | Sertraline Hcl | 112 | 25 |
| Levetiracetam | Levetiracetam | 104 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 100 | 38 |
| Spironolactone | Spironolactone | 98 | 29 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 89 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 89 | 38 |
| Olanzapine | Olanzapine | 87 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 86 | 21 |
| Celecoxib | Celecoxib | 79 | 22 |
| Trulicity | Dulaglutide | 79 | 22 |
| Metoprolol Succinate | Metoprolol Succinate | 77 | 25 |
| Glipizide | Glipizide | 73 | 15 |
| Cephalexin | Cephalexin | 71 | 25 |
| Pioglitazone Hcl | Pioglitazone Hcl | 70 | 13 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 70 | 19 |
| Finasteride | Finasteride | 69 | 13 |
| Aripiprazole | Aripiprazole | 68 | 16 |
| Bupropion Xl | Bupropion Hcl | 68 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 67 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 67 | 13 |
| Bumetanide | Bumetanide | 66 | 12 |
| Donepezil Hcl | Donepezil Hcl | 66 | 18 |
| Lamotrigine | Lamotrigine | 64 | 12 |
| Topiramate | Topiramate | 64 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 55 | 11 |
| Metformin Hcl Er | Metformin Hcl | 55 | 11 |
| Tradjenta | Linagliptin | 53 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 51 | 12 |
| Farxiga | Dapagliflozin Propanediol | 48 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 48 | 18 |
| Divalproex Sodium Er | Divalproex Sodium | 47 | suppressed |
| Methocarbamol | Methocarbamol | 47 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 46 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 25 |
| Hydrocortisone | Hydrocortisone | 44 | 14 |
| Prednisone | Prednisone | 44 | 18 |
| Myrbetriq | Mirabegron | 43 | suppressed |
| Nystatin | Nystatin | 43 | 30 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 42 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 42 | 12 |
| Sucralfate | Sucralfate | 42 | suppressed |
| Torsemide | Torsemide | 40 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 39 | 23 |
| Ondansetron Hcl | Ondansetron Hcl | 39 | 31 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 38 | 18 |
| Chlorthalidone | Chlorthalidone | 37 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 37 | suppressed |
| Risperidone | Risperidone | 37 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 36 | 19 |
| Meloxicam | Meloxicam | 36 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 36 | 11 |
| Famotidine | Famotidine | 35 | 18 |
| Tramadol Hcl | Tramadol Hcl | 35 | 23 |
| Memantine Hcl | Memantine Hcl | 34 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 34 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 34 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 33 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 32 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 31 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 30 | 15 |
| Lactulose | Lactulose | 30 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 30 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 29 | 11 |
| Prazosin Hcl | Prazosin Hcl | 29 | suppressed |
| Ezetimibe | Ezetimibe | 28 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 28 | suppressed |
| Xarelto | Rivaroxaban | 28 | suppressed |
| Allopurinol | Allopurinol | 27 | 11 |
| Benztropine Mesylate | Benztropine Mesylate | 26 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 26 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 26 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 17 |
| Liothyronine Sodium | Liothyronine Sodium | 25 | suppressed |
| Carbamazepine | Carbamazepine | 24 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 24 | 13 |
| Lokelma | Sodium Zirconium Cyclosilicate | 24 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 23 | 17 |
| Levofloxacin | Levofloxacin | 23 | 16 |
| Lorazepam | Lorazepam | 23 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 23 | suppressed |
| Sotalol | Sotalol Hcl | 23 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 22 | suppressed |
| Carbamazepine Er | Carbamazepine | 22 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 22 | suppressed |
| Methotrexate | Methotrexate Sodium | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Misoprostol | Misoprostol | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | 15 |
| Acetic Acid | Acetic Acid | 20 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | 11 |
| Fluconazole | Fluconazole | 19 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 19 | 11 |
| Lacosamide | Lacosamide | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | suppressed |
| Pregabalin | Pregabalin | 19 | suppressed |
| Azithromycin | Azithromycin | 18 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Simvastatin | Simvastatin | 18 | suppressed |
| Calcium Acetate | Calcium Acetate | 17 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 17 | 11 |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 17 | suppressed |
| Cefdinir | Cefdinir | 16 | suppressed |
| Nyamyc | Nystatin | 16 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 14 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 13 | suppressed |
| Clonazepam | Clonazepam | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Movantik | Naloxegol Oxalate | 12 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $20.92 · 1 records | Neurocrine BioSciences, Inc. | INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error